The Cancer Genome Atlas: A Comprehensive Effort to Understand the Molecular Basis of Cancer

Strategic Insights -

The US National Cancer Institute and the US National Human Genome Research Institute, both part of the US National Institutes of Health, have selected the International Genomics Consortium and the Translational Genomics Research Institute to lead the Human Cancer Biospecimen Core Resource component of The Cancer Genome Atlas pilot project. This comprehensive effort aims to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies. By collecting and cataloging cancer specimens and associated clinical data, TCGA will provide a new generation of cancer therapies, diagnostics, and preventive strategies.

Key Takeaways:

  • The Human Genome Project was completed in 2003, marking a significant milestone in understanding human genetics.
  • Cancer is now understood to include more than 200 different diseases, each with unique genomic changes that disrupt cellular pathways.
  • The Cancer Genome Atlas pilot project will collect and analyze cancer specimens from over 250 patients, focusing on specific tumor types.
  • The project will be led by Robert Penny, MD, PhD, who emphasized the importance of accelerating personalized medicine through earlier diagnosis, targeted treatments, and effective prevention.
  • TGen's core competencies in high-throughput genomic analysis will be leveraged to assist with the analytic preparation component of the BCR.
  • The project will be funded by the US National Cancer Institute and the US National Human Genome Research Institute, part of the US National Institutes of Health.

Statistics:

  • Over 200 different diseases are now recognized as part of the cancer spectrum.
  • The Human Genome Project was completed in 2003, defining the human genome sequence.
  • The Cancer Genome Atlas pilot project will focus on analyzing cancer specimens from over 250 patients.
  • TCGA aims to create a comprehensive web-based resource describing the genomic "fingerprints" of specific cancer types.

Sources:

  • National Cancer Institute and National Human Genome Research Institute press release, [Exact date not provided]
  • "Cancer researchers target genetic basis of disease," Health & Medicine Week, [Exact date not provided]
  • The Cancer Genome Atlas pilot project announcement, [No date provided]
  • "Human Genome Project complete," The Human Genome Project Information Archive, [Exact date not provided]